Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cerevel Therapeutics
Biotech
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
The backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in the spotlight.
Nick Paul Taylor
Apr 18, 2024 8:34am
AbbVie grabs a wrench to add immunology-focused Landos Biopharma
Mar 25, 2024 9:20am
AbbVie’s pursuit of Cerevel was CEO Gonzalez's Christmas wish
Jan 7, 2024 8:44pm
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy
Dec 7, 2023 11:26am
AbbVie pads neuroscience portfolio with $8.7B Cerevel deal
Dec 6, 2023 5:19pm
Cerevel swaps CEO—Chutes & Ladders
May 5, 2023 9:30am